http://www.cnr.it/ontology/cnr/individuo/prodotto/ID202150
The influence of anxiety and depression on respiratory drug consumption in a general population sample (Abstract/Poster in convegno)
- Type
- Label
- The influence of anxiety and depression on respiratory drug consumption in a general population sample (Abstract/Poster in convegno) (literal)
- Anno
- 2011-01-01T00:00:00+01:00 (literal)
- Alternative label
G. Viegi, G. Sarno, S. Baldacci, S. Cerrai, S. Maio, M. Fresta, F. Martini, A. Angino, F. Di Pede, F. Cibella (2011)
The influence of anxiety and depression on respiratory drug consumption in a general population sample
in American thoracic society 2011 international conference, Denver, Colorado, May 13 - 18, 2011
(literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
- G. Viegi, G. Sarno, S. Baldacci, S. Cerrai, S. Maio, M. Fresta, F. Martini, A. Angino, F. Di Pede, F. Cibella (literal)
- Pagina inizio
- Pagina fine
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#altreInformazioni
- ID_PUMA: cnr.ifc/2011-A6-004 (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#url
- http://ajrccm.atsjournals.org/content/vol183/1_MeetingAbstracts/index.dtl (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
- Rivista
- Note
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
- National Research Council, Palermo, Italy ; National Research Council, Pisa, Italy (literal)
- Titolo
- The influence of anxiety and depression on respiratory drug consumption in a general population sample (literal)
- Abstract
- Rationale: anxiety and depression are two common comorbidity in subjects with respiratory diseases. The present work is aimed at evaluating, in an Italian general population sample, the influence of anxiety/depression on respiratory drug consumption in subjects with asthma/COPD. Methods: within the European Union funded project IMCA2 (Indicators for Monitoring COPD and Asthma in the EU), a sample of subjects living in Pisa (Central Italy) was selected. An information technology tool allowed to record spirometry and to fill in a core questionnaire on socio-demographic characteristics, respiratory symptoms/diseases, risk factors and anxiety/depression. The Hospital Anxiety and Depression Scale (HADS) was used to obtain confirmation in the anxiety/depression diagnoses. Statistical analyses were performed using the statistical package SPSS 13.0. 'Asthma' is identified by having a previous medical diagnosis or wheezing/whistling, attacks of shortness of breath with wheezes and nocturnal attacks of shortness of breath. 'COPD' is identified by having a previous medical diagnosis of chronic bronchitis, emphysema or chronic cough, chronic phlegm and dyspnoea >= II level. A multinomial logistic regression analysis, adjusted for smoking habits, age, sex, medical examination, was run to assess association between respiratory drug consumption or other drug consumption and: asthma/COPD with anxiety/depression ('AC-AD'); asthma/COPD without anxiety/depression ('AC'); anxiety/depression without asthma/COPD ('AD'); neither anxiety/depression nor asthma/COPD ('NN'). Subjects who didn't use any drug were the reference category. Results: 80.1% of contacted subjects participated (n=977). Analyses concerned 903/977 subjects who filled in HADS questionnaire (mean age:56.5 yrs±18.0; 45.3% male). 7.0% of subjects had 'AC-AD', 27.8 % 'AC', 9.4% 'AD': 30.2% of subjects with 'AC-AD' used respiratory drugs compared to 21.1% of subjects with 'AC' and no subject with only 'AD'. Respiratory drug consumption was significantly associated with 'AC' (OR=12.14; 95% CI=5.56-26.52) and 'AC-AD' (OR=15.21; 95% CI=4.28-53.99). Use of respiratory drugs was also significantly associated with female gender (OR=2.37; 95% CI=1.22-4.60) and medical examination because of breathing problems/shortness of breath (OR=9.25; 95% CI=4.22-20.27). Moreover 'AC', 'AC-AD' and 'AD' were significantly associated with other drug consumption: OR=2.58 (95% CI=1.64-4.06), OR=3.46 (95% CI=1.25-9.51) and OR=2.42 (95% CI=1.33-4.42) respectively. Use of other drug was also significantly associated with age: 46-64 yrs (OR=2.59; 95% CI=1.56-4.31) and >=65 yrs (OR=8.41; 95% CI=4.84-14.60). (literal)
- Prodotto di
- Autore CNR
Incoming links:
- Prodotto
- Autore CNR di
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi